A Claim By Any Other Name - Industry Eyes More Defined Promotional Terms
This article was originally published in The Gray Sheet
Executive Summary
FDA should clarify definitions and relationships between indications for use, intended use and claims, industry representatives suggested June 14 at AdvaMed's 11th Annual Device Submissions Workshop in Washington, D.C.